Talphera (TLPH) Accounts Payables (2010 - 2026)
Talphera (TLPH) posted Accounts Payables of $387000.0 for Q2 2026, down 58.25% on a QoQ basis from $927000.0 in Q1 2026, and down 53.65% year-over-year from $835000.0 in Q2 2025.
Analysis
Talphera (TLPH) Accounts Payables (2010 - 2026) Analysis & Trends
Talphera has reported Accounts Payables for 17 years, with the latest figure at $387000.0 in Q2 2026.
- On a quarterly basis, Accounts Payables fell 53.65% year-over-year to $387000.0 in Q2 2026; TTM through Jun 2026 was $387000.0, a 53.65% decrease from a year earlier, with the FY2025 full-year figure at $544000.0, down 18.81% from the prior year.
- Accounts Payables was $387000.0 for Q2 2026 at Talphera, down from $927000.0 in the prior quarter.
- The five-year high for Accounts Payables was $2.7 million in Q1 2022, with the low at $326000.0 in Q1 2025.
- Average Accounts Payables over 5 years is $1.1 million, with a median of $976500.0 recorded in 2023.
- The sharpest annual moves came in 2025 and 2026: Accounts Payables sank 74.41% in 2025, then soared 184.36% in 2026.
- Over 5 years, Accounts Payables stood at $1.3 million in 2022, then gained by 6.37% to $1.3 million in 2023, then plunged by 49.85% to $670000.0 in 2024, then slipped by 18.81% to $544000.0 in 2025, then fell by 28.86% to $387000.0 in 2026.
- The last three Accounts Payables figures came in at $387000.0 (Q2 2026), $927000.0 (Q1 2026), and $544000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 2.87 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 674.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 429.50 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 1.16 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 167.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 403.90 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 25.08 Mn |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - | 387,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 387,000.00 |
| Mar 31, 2026 | 927,000.00 |
| Dec 31, 2025 | 544,000.00 |
| Sep 30, 2025 | 526,000.00 |
| Jun 30, 2025 | 835,000.00 |
| Mar 31, 2025 | 326,000.00 |
| Dec 31, 2024 | 670,000.00 |
| Sep 30, 2024 | 396,000.00 |
| Jun 30, 2024 | 808,000.00 |
| Mar 31, 2024 | 1.27 Mn |
| Dec 31, 2023 | 1.34 Mn |
| Sep 30, 2023 | 1.03 Mn |
| Jun 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 1.40 Mn |
| Dec 31, 2022 | 1.26 Mn |
| Sep 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 2.40 Mn |
| Mar 31, 2022 | 2.72 Mn |
| Dec 31, 2021 | 2.12 Mn |
| Sep 30, 2021 | 2.23 Mn |